ES2047458A6 - P\rocedimiento para la preparacion de peptido-2 activador de neutrofilos. - Google Patents

P\rocedimiento para la preparacion de peptido-2 activador de neutrofilos.

Info

Publication number
ES2047458A6
ES2047458A6 ES9050004A ES9050004A ES2047458A6 ES 2047458 A6 ES2047458 A6 ES 2047458A6 ES 9050004 A ES9050004 A ES 9050004A ES 9050004 A ES9050004 A ES 9050004A ES 2047458 A6 ES2047458 A6 ES 2047458A6
Authority
ES
Spain
Prior art keywords
lys
ile
leu
gly
asp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9050004A
Other languages
English (en)
Spanish (es)
Inventor
Marco Baggiolini
Kenneth John Clemetson
Alfred Walz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kocher Theodor Institut
Sandoz AG
Original Assignee
Kocher Theodor Institut
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888828728A external-priority patent/GB8828728D0/en
Priority claimed from GB898909681A external-priority patent/GB8909681D0/en
Application filed by Kocher Theodor Institut, Sandoz AG filed Critical Kocher Theodor Institut
Publication of ES2047458A6 publication Critical patent/ES2047458A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES9050004A 1988-12-08 1989-11-17 P\rocedimiento para la preparacion de peptido-2 activador de neutrofilos. Expired - Lifetime ES2047458A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888828728A GB8828728D0 (en) 1988-12-08 1988-12-08 Neutrophil-stimulating activity i
GB898909681A GB8909681D0 (en) 1989-04-27 1989-04-27 Neutrophil-stimulating activity 1

Publications (1)

Publication Number Publication Date
ES2047458A6 true ES2047458A6 (es) 1994-02-16

Family

ID=26294713

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9050004A Expired - Lifetime ES2047458A6 (es) 1988-12-08 1989-11-17 P\rocedimiento para la preparacion de peptido-2 activador de neutrofilos.

Country Status (19)

Country Link
US (1) US5759533A (enExample)
JP (1) JP3051160B2 (enExample)
KR (1) KR910700260A (enExample)
AU (1) AU634508B2 (enExample)
BE (1) BE1003636A4 (enExample)
CA (1) CA2004685A1 (enExample)
CH (1) CH681625A5 (enExample)
DK (1) DK188690A (enExample)
ES (1) ES2047458A6 (enExample)
FI (1) FI903931A0 (enExample)
FR (1) FR2640142B1 (enExample)
GB (1) GB2231872B (enExample)
GR (1) GR1000455B (enExample)
IL (1) IL92557A0 (enExample)
NL (1) NL8921262A (enExample)
NZ (1) NZ231652A (enExample)
PT (1) PT92509A (enExample)
SE (1) SE9002589L (enExample)
WO (1) WO1990006321A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3051160B2 (ja) * 1988-12-08 2000-06-12 ノバルティス・アクチエンゲゼルシャフト 好中球活性化ペプチド‐２
US6673893B1 (en) 1990-02-01 2004-01-06 University Of South Florida Leukocyte derived growth factor 2
CA2075196A1 (en) * 1990-02-01 1991-08-02 Gary R. Grotendorst Leukocyte-derived growth factor
WO1993001826A1 (en) * 1991-07-19 1993-02-04 East Carolina University Method of treating asthma
WO1993009794A1 (en) * 1991-11-15 1993-05-27 University Of Pennsylvania Suppression of megakaryocytopoiesis by neutrophil activating peptide-2
EP0677106A4 (en) * 1993-01-07 1998-12-09 Univ South Florida GROWTH FACTORS MADE OF LEUKOCYTEN.
US5578569A (en) * 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US5912232A (en) * 1994-09-23 1999-06-15 Board Of Regents Of The University Of Nebraska Anti-inflammatory polypeptide antagonists of human I1-8
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
US6117839A (en) * 1995-06-07 2000-09-12 Gensci Regeneration Sciences, Inc. Bone stimulating factor
US5880094A (en) * 1995-06-07 1999-03-09 Osteopharm Limited Polypeptides that stimulate bone growth
US6693081B2 (en) * 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
US6838435B1 (en) 1997-09-25 2005-01-04 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Isolated and recombinant antimicrobial peptides thrombocidin-1 (TC-1) and thrombocidin-2(TC-2) or variants thereof
GB9807721D0 (en) * 1998-04-08 1998-06-10 Chiron Spa Antigen
CA2723031C (en) * 2000-03-07 2014-05-20 Japan Tobacco Inc. Polypeptides having neutrophil stimulating activity
US6815421B1 (en) 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
EP1534752B1 (en) 2002-05-01 2011-08-03 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
US7177246B2 (en) * 2003-09-12 2007-02-13 Hewlett-Packard Development Company, L.P. Optical disk drive focusing apparatus using sum signal
PH12013500990A1 (en) 2010-11-19 2022-11-23 Eisai R&D Man Co Ltd Neutralizing anti-ccl20 antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897348A (en) * 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
DE3737703A1 (de) * 1987-11-06 1989-05-18 Ferring Arzneimittel Gmbh Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum
US5026639A (en) * 1988-01-14 1991-06-25 Nippon Mining Company, Limited Method to improve mRNA translation and use thereof for production of platelet factor-4
JP3051160B2 (ja) * 1988-12-08 2000-06-12 ノバルティス・アクチエンゲゼルシャフト 好中球活性化ペプチド‐２

Also Published As

Publication number Publication date
KR910700260A (ko) 1991-03-14
SE9002589D0 (sv) 1990-08-07
BE1003636A4 (fr) 1992-05-12
GR890100810A (en) 1991-03-15
AU4655689A (en) 1990-06-26
FI903931A7 (fi) 1990-08-08
IL92557A0 (en) 1990-08-31
PT92509A (pt) 1990-06-29
CA2004685A1 (en) 1990-06-08
US5759533A (en) 1998-06-02
FR2640142B1 (fr) 1994-09-23
JPH03503767A (ja) 1991-08-22
WO1990006321A1 (en) 1990-06-14
FI903931A0 (fi) 1990-08-08
DK188690D0 (da) 1990-08-07
AU634508B2 (en) 1993-02-25
DK188690A (da) 1990-08-07
GB2231872B (en) 1992-07-22
NL8921262A (nl) 1990-11-01
NZ231652A (en) 1993-02-25
FR2640142A1 (fr) 1990-06-15
SE9002589L (sv) 1990-08-07
GR1000455B (el) 1992-07-30
CH681625A5 (enExample) 1993-04-30
GB9011468D0 (en) 1990-08-29
GB2231872A (en) 1990-11-28
JP3051160B2 (ja) 2000-06-12

Similar Documents

Publication Publication Date Title
ES2047458A6 (es) P\rocedimiento para la preparacion de peptido-2 activador de neutrofilos.
BR9814276A (pt) Antìgenos de superfìcie
DE68910867D1 (de) Matrix für die transdermale Abgabe von Arzneimitteln.
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
NO885275L (no) Vaskulaere antikoagulantproteiner, dna'er som koder for dem, fremstilling og anvendelse derav.
ES2094923T3 (es) Procedimiento de preparacion de medicamentos conservados que contienen proteinas humanas, para fines de infusion o inyeccion.
BR9714517A (pt) Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
DK0538300T3 (da) O-Glycosyleret IFN-alfa
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
ES2069843T3 (es) Utilizacion de baclofen para la obtencion de medicamentos destinados al tratamiento de la angina de pecho.
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ES2159362T3 (es) Utilizacion de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina para la preparacion de medicamentos destinados para el tratamiento de la esclerosis lateral amiotrofica.
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
BR9915460A (pt) Método de tratamento de febre hemorrágica virótica
IT1232819B (it) Impiego di sorgenti di nucleobasi per stimolare la funzione immunitaria, relativo procedimento e composizioni farmaceutiche contenenti una tale sorgente di nucleobasi
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
ES2139568T3 (es) Complejo proteico.
IT8721560A0 (it) Procedimento per la purificazione di interferone.
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
DE3877747D1 (de) Glasartige matrize zur verabreichung von heilmitteln.
ES535327A0 (es) Mejoras en el objeto de la patente principal n 501.846, por: aparato posicionador para el deshuesado de jamones
BR9205877A (pt) Processo e composiçao para o tratamento de infecçoes por herpes.
ES2052267T3 (es) Anticuerpos anti-rh(d) humanos modificados.
DE3586795D1 (de) Absorptionsverbesserer fuer proteine.
IT1231944B (it) Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19930818